We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-13.57%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$84.5B
AUM Growth
-$745M
Cap. Flow
+$13.7B
Cap. Flow %
16.26%
Top 10 Hldgs %
10.97%
Holding
4,738
New
695
Increased
1,955
Reduced
1,481
Closed
562

Sector Composition

Rank Sector Weight
1 Healthcare 19.41%
2 Technology 16.8%
3 Consumer Staples 11.12%
4 Consumer Discretionary 10.11%
5 Financials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GANX icon
3801
Gain Therapeutics
GANX
$71.7M
$119K ﹤0.01%
+33,100
New +$114K
BYU
3802
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
$119K ﹤0.01%
1,891
-1,792
-49% -$101K
KSCP icon
3803
Knightscope
KSCP
$28.3M
$118K ﹤0.01%
+784
New +$150K
NERV icon
3804
Minerva Neurosciences
NERV
$185M
$118K ﹤0.01%
35,611
-13,133
-27% -$53.7K
VRNA
3805
DELISTED
Verona Pharma
VRNA
$118K ﹤0.01%
+28,200
New +$121K
NBEV
3806
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$118K ﹤0.01%
527,320
+350,620
+198% +$132K
CATX icon
3807
Perspective Therapeutics
CATX
$332M
$117K ﹤0.01%
37,709
-4,023
-10% -$12.3K
ELYS
3808
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$117K ﹤0.01%
+159,029
New +$214K
DBTX
3809
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$116K ﹤0.01%
27,600
+6,685
+32% +$15.8K
ACIC icon
3810
American Coastal Insurance
ACIC
$515M
$115K ﹤0.01%
73,426
-16,800
-19% -$35.6K
AUR icon
3811
Aurora
AUR
$12.6B
$115K ﹤0.01%
+60,400
New +$222K
IGC icon
3812
IGC Pharma
IGC
$26M
$115K ﹤0.01%
+217,749
New +$137K
ALLR
3813
Allarity Therapeutics
ALLR
$19.3M
0
CTRM icon
3814
Castor Maritime
CTRM
$18.8M
$114K ﹤0.01%
8,480
+6,810
+408% +$126K
NNVC icon
3815
NanoViricides
NNVC
$38.8M
$113K ﹤0.01%
60,000
-16,800
-22% -$30.9K
DCOY
3816
Decoy Therapeutics
DCOY
$2.19M
$113K ﹤0.01%
15
+13
+650% +$112K
TSAT icon
3817
Telesat
TSAT
$567M
$113K ﹤0.01%
10,100
-24,000
-70% -$338K
YHGJ icon
3818
Yunhong Green CTI Ltd
YHGJ
$7.54M
$113K ﹤0.01%
15,837
-240
-1% -$2.03K
AXLA
3819
DELISTED
Axcella Health Inc. Common Stock
AXLA
$113K ﹤0.01%
2,228
+272
+14% +$13.4K
ESRT icon
3820
Empire State Realty Trust
ESRT
$872M
$112K ﹤0.01%
15,900
-151,400
-90% -$1.23M
IDN icon
3821
Intellicheck
IDN
$73.1M
$112K ﹤0.01%
55,200
+38,303
+227% +$77.2K
METV icon
3822
Roundhill Ball Metaverse ETF
METV
$209M
$112K ﹤0.01%
+13,900
New +$131K
FNCH
3823
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$110K ﹤0.01%
1,290
-210
-14% -$18K
BDRX
3824
Biodexa Pharmaceuticals
BDRX
$1.19M
0
UDMY
3825
DELISTED
Udemy
UDMY
$109K ﹤0.01%
10,700
-28,900
-73% -$350K

Similar funds

Renaissance Technologies's Q2 2022 Portfolio in Review

As of Q2 2022, Renaissance Technologies held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies deployed $13.7B of net new capital in Q2 2022, opening 695 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.

  • Renaissance Technologies's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
  • Renaissance Technologies added most to Chevron in Q2 2022, an estimated $820M increase.
  • Renaissance Technologies's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
  • Renaissance Technologies fully exited Amazon in Q2 2022, selling an estimated $675M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
  • Renaissance Technologies opened 695 new positions and closed 562 in Q2 2022.
  • Renaissance Technologies's portfolio value fell 0.87% quarter-over-quarter to $84.5B.

Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.